Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: patientman

Nov 07, 2008 06:42AM
6
Nov 07, 2008 07:03AM
6
Nov 07, 2008 07:49AM
3
Nov 07, 2008 08:03AM

Nov 07, 2008 09:39AM

"...the USPTO re-exam is not a "slam dunk."

Until the SHM I would have agreed 100% with you, but how do you understand this phrase from the presentation page 46:



"Capitalize on expected favorable USPTO action on MMP"



This is something which puzzles me:

- First we are told, they can't say anything about the development with the USPTO (in terms of outcome and time),

- then we were told the market is desperately waiting for the re-validation of the USPTO (one of the reasons for the depressed shareprice),

- then we get to know, that Mr. Goerner is "looking forward to the USPTO decision (in his last two letters)

- and now it seems, that we are one step further and EXPECTING a favorable USPTO action!

But it seems, I'm the only one, who sees this "development", because otherwise the shareprice would have gone through the roof with an "favorable USPTO action" to be expected...lol

This is all a blackbox to me - glty

2
Nov 07, 2008 10:30AM
1
Nov 07, 2008 04:10PM
1
Nov 07, 2008 04:11PM
Share
New Message
Please login to post a reply